Robin Reschke (R Reschke)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Dendritic Cells

Immune Response

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Robin Reschke, Alexander H Enk, Jessica C Hassel
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets. International journal of molecular sciences 25 (12) (2024)
Robin Reschke, Alexander H Enk, Jessica C Hassel
T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous Melanoma. Pharmaceutics 16 (8) (2024)
Robin Reschke, Alexander H Enk, Jessica C Hassel
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets. International journal of molecular sciences 25 (12) (2024)
Robin Reschke, Alexander H Enk, Jessica C Hassel
T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous Melanoma. Pharmaceutics 16 (8) (2024)
Robin Reschke, Daniel J Olson
Correction: Reschke, R.; Olson, D.J. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. Cancers 2022, 14 , 2458. Cancers 16 (6) (2024)
Robin Reschke, Daniel J Olson
Correction: Reschke, R.; Olson, D.J. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. Cancers 2022, 14 , 2458. Cancers 16 (6) (2024)
Felix Johnson, Benedikt Hofauer, Markus Wirth, Barbara Wollenberg, Fabian Stögbauer, Susan Notohamiprodjo, Bernhard Haller, Robin Reschke, Andreas Knopf, Ulrich Strassen
Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands. Cancers 15 (15) (2023)
Robin Reschke, Konstantin Dumann, Mirjana Ziemer
Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years). Journal of clinical medicine 11 (7) (2022)
Robin Reschke, Daniel J Olson
Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. Cancers 14 (10) (2022)
Robin Reschke, Jason W Shapiro, Jovian Yu, Sherin Juliet Rouhani, Daniel J Olson, Yuanyuan Zha, Thomas F Gajewski
Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines. Cancer immunology research 10 (10) (2022)
Robin Reschke, Thomas F Gajewski
CXCL9 and CXCL10 bring the heat to tumors. Science immunology 7 (73) (2022)
Robin Reschke, Jovian Yu, Blake Flood, Emily F Higgs, Ken Hatogai, Thomas F Gajewski
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma. Journal for immunotherapy of cancer 9 (9) (2022)
Robin Reschke, Stephanie Zimmerlich, Christine Döhring, Gerhard Behre, Mirjana Ziemer
Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome. Biomedicines 10 (8) (2022)
J Kohlmann, Robin Reschke, M Mockenhaupt, Mirjana Ziemer
Severe skin eruption with features of drug reaction with eosinophilia and systemic symptoms (DRESS) during vemurafenib treatment of melanoma. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Robin Reschke, Philipp Gussek, Mirjana Ziemer
Identifying High-Risk Tumors within AJCC Stage IB-III Melanomas Using a Seven-Marker Immunohistochemical Signature. Cancers 13 (12) (2021)
Robin Reschke, Philipp Gussek, Andreas Boldt, Ulrich Sack, Ulrike Köhl, Florian Lordick, Thomas Gora, Markus Kreuz, Kristin Reiche, Jan-Christoph Simon, Mirjana Ziemer, Manfred Kunz
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy. International journal of molecular sciences 22 (15) (2021)
Thomas Gajewski, Sherin Rouhani, Jonathan Trujillo, Athalia Pyzer, Jovian Yu, Jessica Fessler, Alexandra Cabanov, Emily Higgs, Kyle Cron, Yuanyuan Zha, Yihao Lu, Jeffrey Bloodworth, Mustafa Abasiyanik, Susan Okrah, Blake Flood, Ken Hatogai, Michael Leung, Apameh Pezeshk, Lara Kozloff, Robin Reschke, Garth Strohbehn, Carolina Soto Chervin, Madan Kumar, Stephen Schrantz, Maria Lucia L Madariaga, Kathleen Beavis, Kiang-Teck Yeo, Randy Sweis, Jeremy Segal, SavaÅŸ Tay, Evgeny Izumchenko, Jeffrey Mueller, Lin Chen
Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction. Research square (2021)